药物对比
Dapagliflozin vs Dulaglutide
Dapagliflozin 与 Dulaglutide 治疗2型糖尿病的比较。SGLT2与GLP-1：口服与注射、心脏/肾脏获益、减重及安全性。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting between an oral SGLT2 inhibitor and a weekly injectable GLP-1 agonist for type 2 diabetes with cardiovascular or kidney considerations.
结论
Both Dapagliflozin and Dulaglutide deliver meaningful glucose control plus organ protection, making the preferred agent dependent on route, specific risks, and patient priorities.
全部药物对比